| 前收盘价格 | 9.20 |
| 收盘价格 | 9.24 |
| 成交量 | 185,083 |
| 平均成交量 (3个月) | 479,874 |
| 市值 | 322,414,272 |
| 市盈率 (P/E TTM) | 130.43 |
| 预期市盈率 (P/E Forward) | 25.77 |
| 价格/销量 (P/S) | 4.39 |
| 股市价格/股市净资产 (P/B) | 2.93 |
| 52周波幅 | |
| 利润日期 | 7 May 2026 |
| 营业毛利率 | -26.38% |
| 营业利益率 (TTM) | 3.24% |
| 稀释每股收益 (EPS TTM) | -0.450 |
| 季度收入增长率 (YOY) | 530.30% |
| 总债务/股东权益 (D/E MRQ) | 1.27% |
| 流动比率 (MRQ) | 15.95 |
| 营业现金流 (OCF TTM) | -6.89 M |
| 杠杆自由现金流 (LFCF TTM) | -7.11 M |
| 资产报酬率 (ROA TTM) | -1.51% |
| 股东权益报酬率 (ROE TTM) | -28.13% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Delcath Systems, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.00 |
|
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Core |
| 内部持股比例 | 2.73% |
| 机构持股比例 | 45.84% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Rosalind Advisors, Inc. | 31 Dec 2025 | 3,300,389 |
| Divisadero Street Capital Management, Lp | 31 Dec 2025 | 499,796 |
| Exoduspoint Capital Management, Lp | 31 Dec 2025 | 496,705 |
| Propel Bio Management, Llc | 31 Dec 2025 | 438,509 |
| Ikarian Capital, Llc | 31 Dec 2025 | 431,251 |
| Private Wealth Advisors, Llc | 31 Dec 2025 | 290,481 |
| Palisades Investment Partners, Llc | 31 Dec 2025 | 267,138 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (HC Wainwright & Co., 228.59%) | 购买 |
| 中 | 24.50 (168.35%) | |
| 低 | 19.00 (BTIG, 108.11%) | 购买 |
| 平均值 | 24.50 (168.35%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 9.67 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 26 Feb 2026 | 19.00 (108.11%) | 购买 | 9.00 |
| HC Wainwright & Co. | 09 Jan 2026 | 30.00 (228.59%) | 购买 | 10.34 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合